This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Index funds carry risks for retirees, including sequence of returns and drawdown volatility. Learn strategies to mitigate these concerns.
22,186 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Four giants could join the exclusive $3 trillion club by 2027. This article breaks down the drivers, the risks, and h...
Modine Manufacturing sits at a compelling crossroads as data centers expand. This primer outlines why investors may w...
Arm stock skyrocketed this week as AI enthusiasm and licensing momentum collided with bullish analyst coverage. This ...
A fresh AI chip IPO in 2026 could redefine how growth looks in semiconductors. This article breaks down why the stock...
If you could pick just one tech stock to own, which name would you choose? This in-depth look explains why a single p...
Investors nudged Intel higher after AI infrastructure news signaled stronger demand for its CPU and accelerator lineu...
When a high-ranking executive sells stock, investors scramble for answers. This article breaks down the move by fermi...
Casey's General Stores stock jumped after a robust earnings report that topped expectations. This guide breaks down w...
Amazon’s biggest growth lever may not be its storefront. This article explains how AWS and AI spending could fuel a ...
Investors are buzzing after Simulations Plus announced a cash buyout at $18.50 per share. This deep-dive explains why...
A glamorous opal suite with a surprising backstory sheds light on how provenance, rarity, and celebrity connections c...